TY  - JOUR
AU  - Pérez de Llano, Luis A
AU  - Cosío, Borja G
AU  - Lobato Astiárraga, Ignacio
AU  - Soto Campos, Gregorio
AU  - Tejedor Alonso, Miguel Ángel
AU  - Marina Malanda, Nuria
AU  - Padilla Galo, Alicia
AU  - Urrutia Landa, Isabel
AU  - Michel de la Rosa, Francisco J
AU  - García-Moguel, Ismael
AU  - Reslizumab Real-Life Spanish Group
PY  - 2022
DO  - 10.2147/JAA.S340562
SN  - 1178-6965
UR  - http://hdl.handle.net/10668/20467
T2  - Journal of asthma and allergy
AB  - Reslizumab is an anti-interleukin 5 monoclonal antibody that has demonstrated to reduce the risk of severe exacerbations and to improve symptoms, lung function, and quality of life in randomized controlled trials that included patients with severe...
LA  - en
KW  - asthma control
KW  - eosinophilic asthma
KW  - monoclonal antibodies
KW  - reslizumab
TI  - Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Reslizumab: Spanish Real-Life Data.
TY  - research article
VL  - 15
ER  -